Skip to content

DOKTER P. MUYLAERT

Active Private limited companyfounded 2003active for 23 yearsTer Cleye 27, 9820 Merelbeke-MelleKBO/BCE: BE 0479.280.958

Lifetime

17 annual accounts with figures on one time axis, 22 filings since 2004
peak of €317,192 in 2025
€317,192▲ 42.9%
lowest -€13,414 in 2012
€207,806▲ 37.1%
peak of €657,789 in 2025
€657,789▲ 38.8%
€50,962▼ 10.3%
peak of 1.5 FTE in 2013
-not published
Board1 name since 2003
1 director
Documentsfilings and deeds
09-01-202622 days before the deadline
2025micro format
Gross margin from €222,037 to €317,192Result from €151,542 to €207,806Dividend €24,000Equity from €473,983 to €657,789

Key points

from the 2025 annual accounts

Equity

€657,789 ▲ 38.8%

DOKTER P. MUYLAERT has made a profit without a break since 2018.

Filings

22 annual accounts since 2004
deadline20102020

The last five annual accounts were filed 1 to 27 days before the end of the period.

Position in the sector

€207,806

Higher net result than 89% of companies in human health. The sector median is €59,541, over 21,360 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as DOKTER P. MUYLAERT has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for DOKTER P. MUYLAERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 17-10-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0479280958
changes role from statutory manager to director Discharge granted to (manager) · General meeting of 17-10-2023 · Gazette deed
reappointed as statutory manager General meeting of 03-04-2019 · Gazette deed
Incorporation published on 22-01-2003 · Gazette deed
All 37 events

Comparable companies

same main activity, similar in size and age
Company
DOKTER P. MUYLAERT Merelbeke-Melle €708,751 €317,192 92.8% -
Dr. Christian HANTSON, huisarts Ronse €861,063 €335,269 98.6% -
DOCTEUR COULON Nandrin €644,787 €275,539 75.1% -
Dr Katia Mekeirele Waregem €707,417 €386,792 94.5% -
DOKTERS ROGGEN Diepenbeek €962,050 €319,110 85.9% -
DOKTER ERIC VANDEPUTTE Deerlijk €932,408 €283,716 72.2% -
Dr. Geert Massant, algemene geneeskunde Aarschot €662,944 €268,905 79.3% -

These companies have the same main activity as DOKTER P. MUYLAERT: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €645,000 and €962,000, founded between 1997 and 2008.

Official details

Source: KBO
Status
Active since 14-01-2003Normal situation
Activity
Medical imaging and medical laboratoriesNACE 86910and 1 other
Establishment unit
2.291.969.2509820 Merelbeke-Melle, since 14-01-2003
Financial year end
30 June
Peppol
Reachable since 10-12-2025
Company details

Annual accounts to 30-06-2025

≈ €470,000estimated
€708,751▲ 33.5%
Filing
Filed on 09-01-2026, 22 days before the end of the filing period
Financials

Insights on DOKTER P. MUYLAERT

DOKTER P. MUYLAERT files the micro format. That format states no turnover. The gross margin rose from €38,352 in 2009 to €317,192 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOKTER P. MUYLAERT

What is the company number of DOKTER P. MUYLAERT?
The company number of DOKTER P. MUYLAERT is 0479.280.958. The VAT number is the same number with BE in front: BE 0479.280.958.
Where is DOKTER P. MUYLAERT based?
The registered office is at Ter Cleye 27, 9820 Merelbeke-Melle.Company details
What does DOKTER P. MUYLAERT do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of DOKTER P. MUYLAERT?
DOKTER P. MUYLAERT is a private limited company (BV).
When was DOKTER P. MUYLAERT founded?
DOKTER P. MUYLAERT was founded on 14-01-2003.
Is DOKTER P. MUYLAERT still active?
Yes, DOKTER P. MUYLAERT is an active enterprise in the KBO register.
What is the turnover of DOKTER P. MUYLAERT?
The turnover in financial year 2025 is about €470,000. This figure is estimated from the gross margin of €317,192 and 48 comparable companies (NACE 86). It probably lies between €390,000 and €590,000.Financials
Is DOKTER P. MUYLAERT profitable?
In financial year 2025, DOKTER P. MUYLAERT made a profit of €207,806.
Where can I find the annual accounts of DOKTER P. MUYLAERT?
DOKTER P. MUYLAERT filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER P. MUYLAERT due?
DOKTER P. MUYLAERT must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.